Acetazolamide
- Product NDC
- 68382-076
- 11-digit product format
- 683820076
- Labeler code
- 68382
- Product ID
- 68382-076_f3f5740a-6137-468d-8dfb-fda06361592d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- ANDA206533
- Marketing category
- ANDA
- Marketing start
- 2020-01-09
- Marketing end
- 0000-00-00
- Substance
- ACETAZOLAMIDE SODIUM
- Active strength
- 500 mg/5mL
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68382-076 | ACETAZOLAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ZYDUS PHARMACEUTICALS USA INC.] | 2 | Legacy NDC | 20221118_490032a5-132f-4870-90ec-6036218cbfe8.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68382-076-10 | 68382007610 | 1 VIAL in 1 CARTON (68382-076-10) > 5 mL in 1 VIAL | 1 vial | 2020-01-09 | 0000-00-00 | No | No | Current |